The N-terminal region of alpha-dystroglycan is an autonomous globular domain
a-Dystroglycan, a highly 0-and N-glycosylated peripheral membrane protein, is tightly associated with the membranespanning /?-dystroglycan to form part of the dystrophin-glycoprotein complex (Ervasti and Campbell, 1991 ; Ibraghimov-Beskrovnaya et al., 1992; Tinsley et al., 1994) . This complex also includes the membrane-spanning a, P and y sarcoglycans and a 2.5-kDa non-glycosylated protein and constitutes a crucial molecular linker between the extracellular matrix and the internal cytoskeleton (Ervasti and Campbell, 1993) . In particular, adystroglycan directly connects viu calcium-dependent laminin binding basement membranes to the cells, providing mechanical stability to several different tissues (Ervasti and Campbell, 1993 ; Durbeej et al., 199.5 ). a-Dystroglycan binds to globular G-domains which are present at the C-terminal of both laminin and agrin (Gee et al., 1993; Brancaccio et al., 199.5a; Gesemann et al., 1996) but it is not yet known which region of a-dystroglycan is responsible for this activity.
From the deduced amino acid sequence a-dystroglycan molecular mass is =74 kDa but the protein is highly O-glycosy- Note. The amino acid sequence published here has been deposited with the EMBL data bank and is available under accession number X86073.
lated. There are two consensus sequences (Asn-Xaa-Ser) for Nglycosylation, the first in the N-terminal region and the other in the C-terminal one. In skeletal muscle glycosylation amounts to =SO% of the total mass (-1.56 kDa) and even the least glycosylated form from brain (total mass =120 kDa) contains -40% carbohydrates (Ibraghimov-Beskrovnaya et al., 1992) . Glycosylation seems to be crucial for dystroglycan function and prevents fragmentation of the protein Campbell, 1991, 1993 ; Henry and Campbell, 1996) . Its glycosylation pattern is poorly understood, but a recent carbohydrate analysis points towards the presence of extensive mucin-like 0-glycosylation (Smalhaiser and Kim, 1995) . a-Dystroglycan could harbour heparansulphate glycosaminoglycan chains since heparin inhibits its binding to laminin and agrin (Gee et al., 1993; Brancaccio et al., 199Sa) . Heparan sulphate may not however be directly involved in binding because the a-dystroglycan-binding site of agrin is close to but separated from the heparin-binding site (Gesemann et al., 1996) .
The structural organization of a-dystroglycan has not yet been clarified. No similarity to other proteins has been found (Ibraghimov-Beskrovnaya et al., 1992; Henry and Campbell, 1996) . Only for the central part with a high fraction of Pro and Thr, a mucin-like structure (Hilkens et al., 1992; Gum et al., 1992; Li et al., 1996) has been proposed (Brancaccio et al., 199Sa) . The dumbbell-like shape of two globes connected by an elongated rod supports this notion (Brancaccio et al., 1995a) .
To investigate whether in a-dystroglycan the N-terminal region folds autonomously, we decided to express in Escherichia coli two N-terminal fragments of mouse a-dystroglycan whose cDNA sequence we have recently cloned and sequenced (Brancaccio et al., 1995b) . Our results indicate that the N-terminal part of cx-dystroglycan (a) is able to fold even in the absence of glycosylation; (b) has a globular shape and structural features similar to those of loop-containing proteins; and (c) does not bind to agrin and laminin in a nanomolar concentration range.
Preliminary results have been presented at the XVth Meeting of the Federation of the European Connective Tissue Societies (Munich, August 4th to 9th, 1996) .
MATERIALS AND METHODS
Expression and purification of recombinant a-dystroglycan fragments. The full-length cDNA sequence for a-dystroglycan was generated from the murine skeletal muscle cell line C2C12 using reverse-transcriptase PCR standard procedures, and further cloned in the pGEM vector (Promega) as described elsewhere (Brancaccio et al., 1995b) . This sequence was used as a PCR template to generate the DNA constructs encoding the N-terminal protein fragments. For cloning purposes DGN-(30-180)-peptide starts with foreign residues Gly-Ser and DGN-(30-438)-peptide with Gly-Ser-Arg-Val-Asp. Oligonucleotide primers were used to amplify the sequences of interest. For DGN-(30-180)-peptide: 5'-CCC GGA TCC CAC TGC CCC AGT GAA CCC TCA GAGG-3' and 5'-CCC GAA TTC TTA AGA TGG CAC TAC CTC ACC AGG GTC T-3' (BamHI and EcoRl restriction sites in bold, and target sequences underlined). For DGN-(30-438)-peptide: 5'-CCC GTC GAC CAC TGG CCC AGT GAA CCC TCA GAGG-3' and 5'-CCC GAA TTC TTA TGA AGG CGT TGC TGG CTT TGG CGTG-3' (Sull and EcoRl restriction sites in bold, and target sequences underlined). DNA sequences were cloned in a bacterial expression vector (pPEP) which permits high level of expression (Brandenberger et al., 1996) and contains an N-terminal His, tag and a thrombin cleavage site. Overnight cultures were diluted 1 : 100, grown up to an absorbance of 0.8 at 600 nm and then induced for 3-4 h with 1 mM isopropyl P-D-thiogalactopyranoside at 30°C. After cell lysis, proteins were purified using nickel nitrilotriacetate affinity chromatography. The purified fusion proteins were incubated with thrombin (0.5 U/mg fusion protein) for 6 h at room temperature. Protein fragments of interest were finally separated from the carrier protein with a new passage on the same nickel column and collected in the flow-through and/or in the washing fraction. SDS/PAGE was used to check purity (Laemmli, 1970) .
Both DGN-(30-180) and peptides showed the expected sizes (respectively -16 kDa and =44.5 kDa) on SDS/ PAGE and their N-termini were checked by protein micro-sequencing. Absorption coefficients [30000 M ~ cm-' for DGN-(30-180)-peptide and 50000 M-' cm-' for DGN-(30-438)-peptide] were measured using the method of Gill and von Hippel (1 989) .
Trypsin digestion. Protein samples (1-5 yM) were incubated with 16 nM trypsin at 22°C in 10 mM Tris, 150 mM NaCI, pH 7.4 (Tris/NaCI). Reactions were stopped at different times by incubating the sample in SDS buffer for 10 min at 95°C. Reaction products were analyzed by means of SDS/Tricine/ PAGE (Schagger and von Jagow, 1987) .
Fluorescence. Fluorescence emission spectra between 300-400 nm (excitation at 280 nm) were recorded at 22°C using a Jasco FP-777 spectrofluorimeter in 20 mM sodium phosphate pH 6.5 containing different concentrations of denaturating agent using a 0.5-cm cuvette. Protein concentration was 2 yM. Every measurement was made after at least 20 min of incubation with Gdn/HCI. Ultrapure Gdn/HCl was purchased from Nigu Chemie GmbH.
Circular dichroism. Circular dichroic spectra were recorded at 22°C in a 0.2-cm quartz cell, using a Jasco 5-720 spectropolarimeter. Spectra are the average of multiple accumulations. Spectra were noise-reduced using standard procedures and expressed as mean molar residue ellipticity [HI (deg cm2 dmol ') equal to [0] ,,,/(10 c . n . I), where [Q],,, is the measured ellipticity (mdeg), c is the protein concentration (M), n is the number of amino acid residueskhain, and 1 is the path-length of the cell (cm).
Electron microscopy. Rotary shadowing experiments were performed as described by Engel (1994) . Samples were extensively dialyzed against 100 mM NH,HCO, pH 7.9 and sprayed at a concentration of 10-20 pg/ml.
Analytical ultracentrifugation. A Beckman model XLA analytical ultracentrifuge was employed. Sedimentation velocity runs were performed in 12-mm DS Epon cells at 56000 rpm at 20°C in 10 mM sodium phosphate, 150 mM NaCl pH 7.0. Sedimentation equilibrium runs were performed using the same cells also at 20°C but at a filling height of 2-3 mm only in addition to FC-43 bottom fluid. Rotor speeds were adapted to the different molar masses: 32000 rpm for DGN-(30-180)-peptide and 18000 rpm for DGN-(30-438)-peptide. Molar masses were determined using a computer program that adjusts the baseline absorbance to produce the best linear fit of InA versus rZ ( A = absorbance, Y = distance from the rotor center). In all cases a partial specific volume of v = 0.73 ml/g was used. Sedimentation coefficients were corrected to the viscosity and density of water using standard procedures (Van Holde, 1985) .
Solid-phase radio ligand-binding assays. A 95-kDa C-termind fragment of chicken agrin which contains the two globular domains ((31 and G2) sufficient for a-dystroglycan binding was recombinantly expressed (Gesemann et al., 1996) . Laminin-1 was purified from Engelbreth-HoIm-Swarm murine tumor (Paulsson et al., 1987) and iodinated as described by Gesemann et al. (1996) . Chicken skeletal muscle a-dystroglycan was purified from freshly frozen tissues using a protocol similar to that reported by Brancaccio et al. (1995a) . 100 yl tissue-derived (at -5 nM concentration) or recombinant a-dystroglycan (at -20 nM concentration) were coated on microtiter plates by overnight incubation at 4°C in 50 mM NaHCO, pH 9.6. Agrinbinding experiments were performed in Tris/NaCI pH 7.4 containing 1.25 mM CaCI, and 1 mM MgCl, as described elsewhere with minor modifications (Gesemann et al., 1996) . Each datapoint represents the average of triplicate measurements. Unspecific binding (e.g. binding in the presence of an excess of unlabeled agrin fragment) was subtracted from each data point. Data referring to tissue-purified a-dystroglycan binding to agrin were fitted by nonlinear regression analysis using a single class of binding sites equation in which radioactivity (cpm) is equal to (c . B)/(K, + c), where K, is the binding dissociation constant, c the concentration of c95,,,, and B is the radioactivity at total saturation.
RESULTS
a-Dystroglycan N-terminal fragments : expression and stability. Fig. 1 shows an alignment of human, rabbit and mouse sequences. The N-terminus in the native protein is blocked, but His30 may be assigned as the first residue according to the proposed signal sequence (Ibraghimov-Beskrovnaya et al., 1992) . Two recombinant fragments were prepared which start at His30. The first ends at position 180 and the second at position 438 and its sequence contains part of the mucin-like region (Fig. 1) . Fig. 2 shows SDSPAGE analysis of the fusion products purified by nickel affinity chromatography. Both DGN-(30- (Ibraghimov-Beskrovnaya et al., 1992) . Cys residues are marked by arrows, and Trp by closed circles. In the C-and N-terminal parts of the sequence potential sites for N-linked glycosylation are indicated by asterisks and putative 0-linked sites by open triangles. The central part of the sequence (residues 316-384) contains up to 40% of Pro and Thr residues, and is heavily glycosylated (see also Henry and Campbell, 1996) . 180)-peptide and DGN-(30-438)-peptide fusion proteins were obtained directly in soluble form without using any denaturating agent. This is often considered as a first positive indication for the achievement of a correct folding in the expression of a recombinant protein (Makride, 1996) . Moreover, the protein fragments are still soluble after thrombin cleavage and purification ( Fig. 3A and B) . Some degradation was observed during DGN-(30-438)-peptide purification (data not shown). Partial sequencing indicated the same N-terminus for these fragments, indicating that degradation occurred from the C-terminus and is possibly due to the absence of structure in the mucin-like region of the protein. Resistance to protease digestion of correctly folded domains is a common probe for proper folding of recombinant fragments (Maurer et al., 1992; Pokutta et al., 1994) .
Limited proteolysis has been successfully used to investigate domain organization of several multi-modular extracellular matrix proteins (Beck et al., 1990) .
After trypsin incubation, DGN-(30-180)-peptide undergoes only a slight reduction of its molecular size (Fig. 3A) . This result indicates the presence of a significant amount of structural organization in the final 15-kDa fragment (Fig. 3A, arrow) . DGN-(30-438)-peptide was cleaved into fragments of about 30 kDa and 15 kDa (Fig. 3B, arrows) . N-terminal micro-sequencing indicated that the 30-kDa fragment starts from His30 while the 15-kDa band contains two sequences starting from His30 and from Ala169. This indicates that the 30-kDa fragment is divided into two peptides of similar size. The first, residues 30-168, is similar to the 15-kDa band observed as the proteo- lytically stable fragment of DGN-(30-180)-peptide ( Fig. 3 A) ; the second likely ends at a residue between positions 309-313 (see Fig. 1 ).
DGN-(30-438)-peptide fluorescence and circular dichroism.
The N-terminal region of a-dystroglycan contains tryptophan residues in positions 31, 42, 107, 110, 260, and 297 (see Fig. 1 ) making DGN-(30-438)-peptide well suited to fluorescence analysis. Its emission maximum at 438 nm indicates that the tryptophan residues are buried in the protein structure (Schmid, 1990) , suggesting that DGN-(30-438)-peptide has a folded structure (Fig. 4A) . Moreover, increasing concentrations of guanidinium hydrochloride (Gdn/HCI) produce a clear red-shift to 455 nm (Fig. 4A ) and a sharp and cooperative transition curve typical of an unfolding process (Fig. 4 B ; Schmid, 1990) . Circular dichroism of DGN-(30-438)-peptide was recorded at 22°C between 185-250 nm (Fig. 4C ). This spectral shape indicates low levels of typical a or p secondary structures, and is similar to those recorded for loop-containing proteins: a positive peak between 180-185 nm and a reduction of negative signal between 200-250 nm (for example elastase, see Johnson, 1990) . Denaturation also reduces the ellipticity of DGN-(30-438)-peptide (Fig. 4 C) and a Gdn/HCI transition curve similar to that shown in Fig. 4 B was obtained by circular dichroism (data not shown). Van Holde (1985) suggest an overall globular structure for u-dystroglycan N-terminal domain. monly used approach to visualize the shape of large extracellular matrix proteins (Engel, 1994) . Rotary shadowing of purified DGN-(30-438)-peptide samples reveals the presence of molecules which have a globular shape and a homogeneous size (Fig. 5A) . These globes represent the N-terminal domain of adystroglycan (size = 30 kDa from trypsin experiment, Fig. 3 B) . Thin rods extending from the globular domain are occasionally observed (Fig. 5 B) , which most likely represent part of the mucin-like region. The dimensions of the recombinant N-terminal a-dystroglycan doinain are in agreement with those measured for intact a-dystroglycan (Fig. 5 C) .
DGN-(30-438)-peptide electron microscopy and analytical centrifugation. Electron microscopy is a powerful and com-
Moreover, analytical ultracentrifugation data also indicate that the N-terminal part of a-dystroglycan has a globular shape. Experimental values (Table 1) The N-terminal domain of a-dystroglycan does not bind to agrin and laminin. In contrast to tissue-purified a-dystroglycan, DGN-(30-438)-peptide shows no interaction with a 95-kDa iodinated C-terminal fragment of agrin in a solid-phase assay (Fig. 6) . Moreover, increasing concentrations of soluble DGN-(30-438)-peptide (up to a few micromolar) were also unable to compete with the interaction between chicken skeletal muscle adystroglycan and the agrin fragment (data not shown). No binding was detected either to iodinated laminin-I.
DISCUSSION
The main difficulty in elucidating the domain organization and the structural features of a-dystroglycan is due to the absence of significant similarity to other proteins. On the basis of sequence analysis and electron microscopy data, we have previously proposed that a-dystroglycan contains two globular domains separated by a central elongated mucin-like region (Brancaccio et al., 199Sa) .
We were now able to express and study recombinant fragments of the a-dystroglycan N-terminal region. The results indicate that the region approximately between residues 30-315 is an independently folding globular domain as indicated by the expression in soluble form, the resistance against trypsin digestion, the electron microscopic and hydrodynamic shape and by a sharp denaturation profile. A fragment starting at His30 and ending at Ala300 was not soluble (data not shown), indicating that the loss of about 15 C-terminal residues prevents folding. Our data indicate that folding of the u-dystroglycan N-terminal domain is not prevented in the absence of glycosylation.
A plausible schematic description of a-dystroglycan domain organization and of its N-terminal region is shown in Fig. 7 . Analysis of the fragments obtained after trypsin incubation suggest two possible subdomains in the regions 30-160 and 180-315. They are separated by a stretch of poorly conserved residues with characteristics of an exposed linker sequence (Fig. 1) . A potential trypsin cleavage site is located at Arg168.
Far-ultraviolet circular dichroism analysis suggests that the a-dystroglycan N-terminal domain has a loop-containing structure. In fact, the DGN-(30-438)-peptide spectrum is similar to that reported for elastase, a well-known loop-containing matrix metallo-protease (Johnson, 1990) . The sequence of a-dystroglycan from His30 to Asn302 has an about 20% identity (not shown) with murine macrophage elastase (Shapiro et al., 1992) . This identity range is in the 10-25% twilight zone in which unambiguous relationships are difficult to determine (Gray and Doolittle, 1992) . Loop regions are defined as aperiodic segments which connect a-helices and p-strands. They are common in many proteins and often important functional sites are located on loops (Martin et al., 199.5) . A loop-containing structure, stabilized by the presence of four disulfide bridges, was recently found in LE (EGF-like) domains of laminin which are involved in nidogen binding (Stetefeld et al., 2996) .
We have previously speculated that the N-terminal region of a-dystroglycan is oriented towards the extracellular space and thus represents the binding site to the extracellular matrix binding partners (Brancaccio et al., 1995a ; see also Henry and Campbell, 1996) . Our data show that the recombinant a-dystroglycan N-terminal domain does not bind to agrin and laminin in a nanomolar concentration range. This means either that the binding site is present in a different part of the molecule or that glycosylation is essential for binding. A crucial role of glycosylation for binding would confirm earlier experiments by Ervasti and Campbell (1993) and more recently by Chiba et al. (1997) . It is unlikely however that the observed lack of laminin and agrin binding originates from the absence of glycosylation in the N-terminal globular region. The domain is poorly glycosylated Fig. 1 ) and partial trypsin digestion indicate a spacer between two putative subdomains (residues 160-180). The site of observed trypsin cleavage (arrowhead) and putative N-glycosylation (asterisks) and 0-glycosylation (open triangles) sites are indicated. The mucin-like region which connects the N-terminal domain with a putative C-terminal domain in the dumbbell-shaped a-dystroglycan is shown.
since only two putative sites are present (Ser90 and Asnl41). The highly glycosylated central mucin-like domain is a strong candidate for laminin and agrin binding.
Biophysical and structural work including an X-ray diffraction analysis can however be performed preferentially with none or only moderately glycosylated domains. Many structural studies were very successfully performed with proteins recombinantly expressed in E. coli, even when glycosylation sites were not occupied (Bork et al., 1996) . Our present work demonstrates that a bacterially expressed N-terminal fragment of a-dystroglycan contains its N-terminal autonomously folding domain. We have recently achieved very similar results with a somewhat smaller fragment (positions 30-315, see Figs 1 and 7) which lacks the mucin-like domain. This fragment also folded to a trypsin-resistant structure and was very homogeneous according to electron microscopy and ultracentrifugation. It will now be used for further structural investigations.
